Shares of Kairos Pharma Ltd. (KAPA), which gained nearly 6.29 % yesterday, are up another 20% in premarket hours today, trading at $1.92.
This clinical-stage biopharmaceutical company focused on developing cancer therapies will be presenting a talk on its investigational compound KROS 101 at the 13th AACR-JCA Joint Conference tomorrow.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com